Factors Influencing the Adoption of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Painful Bone Metastases in Europe, A Group Concept Mapping Study
: Galendi Julias Simões Correa, Siefen Ann-Cathrine, Moretti DeboraM, Yeo Sin Yuin, Grüll Holger, Bratke Grischa, Morganti Alessio Giuseppe, Bazzocchi Alberto, Gasperini Chiara, De Felice Francesca, Blanco Sequeiros Roberto, Huhtala Mira, Nijholt Ingrid M, Boomsma Martijn F, Bos Clemens, Verkooijen Helena M, Müller Dirk, Stock Stephanie
Publisher: MDPI
: 2023
: International Journal of Environmental Research and Public Health
: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
: INT J ENV RES PUB HE
: 1084
: 20
: 2
: 14
: 1661-7827
DOI: https://doi.org/10.3390/ijerph20021084
: https://www.mdpi.com/1660-4601/20/2/1084
: https://research.utu.fi/converis/portal/detail/Publication/178862316
Magnetic resonance imaging-guided high-intensity focused ultrasound (MR-HIFU) is an innovative treatment for patients with painful bone metastases. The adoption of MR-HIFU will be influenced by several factors beyond its effectiveness. To identify contextual factors affecting the adoption of MR-HIFU, we conducted a group concept mapping (GCM) study in four European countries. The GCM was conducted in two phases. First, the participants brainstormed statements guided by the focus prompt "One factor that may influence the uptake of MR-HIFU in clinical practice is...". Second, the participants sorted statements into categories and rated the statements according to their importance and changeability. To generate a concept map, multidimensional scaling and cluster analysis were conducted, and average ratings for each (cluster of) factors were calculated. Forty-five participants contributed to phase I and/or II (56% overall participation rate). The resulting concept map comprises 49 factors, organized in 12 clusters: "competitive treatments", "physicians' attitudes", "alignment of resources", "logistics and workflow", "technical disadvantages", "radiotherapy as first-line therapy", "aggregating knowledge and improving awareness", "clinical effectiveness", "patients' preferences", "reimbursement", "cost-effectiveness" and "hospital costs". The factors identified echo those from the literature, but their relevance and interrelationship are case-specific. Besides evidence on clinical effectiveness, contextual factors from 10 other clusters should be addressed to support adoption of MR-HIFU.
